Impact of renal dysfunction and glucometabolic status on one month mortality after acute myocardial infarction

Abstract

Patients with impaired glucometabolic status or renal function have a higher mortality after acute myocardial infarction. It is unclear whether this higher risk is independent or related to the quality of care. In a prospective registry, stress hyperglycaemia (SH) was defined as glucose level>140 mg/dl. Renal function was assessed by the glomerular filtration rate (GFR): normal (⩾60), mild (30–60) and severe dysfunction (<30 ml/min/1.72 m²). The level of risk was assessed by the TIMI risk index and the quality of care by the rate of use of five guidelines‐recommended treatments. Among the 1388 patients included, 23% had diabetes, 16% had SH, renal function was normal in 55%, mildly impaired in 35% and severely impaired in 9.5%. At one month, the mortality rate was higher in patients with SH (18%) as compared with diabetics (9%) or those with normal glucometabolic status (5%). Similarly, the mortality rate was higher in those with impaired renal function. Multivariable analysis identified SH, GFR group, TIMI risk index, ST segment elevation MI and quality of care as independent predictors of one‐month mortality. In patients with acute MI, SH and GFR<30 ml/min/m² are independent predictors of mortality after adjustment for the level of risk and acute care.

• Acute cardiac care
• Myocardial infarction
• Risk score
• Stress hyperglycaemia
• Renal dysfunction